ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 122 filers reported holding ANIKA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $758,706 | -76.1% | 40,725 | -66.7% | 0.00% | -100.0% |
Q2 2023 | $3,174,600 | -13.1% | 122,194 | -4.0% | 0.00% | 0.0% |
Q1 2023 | $3,654,821 | +92732.6% | 127,257 | -4.3% | 0.00% | -33.3% |
Q4 2022 | $3,937 | -99.9% | 133,013 | +11.4% | 0.00% | +50.0% |
Q3 2022 | $2,842,000 | +27.4% | 119,391 | +19.5% | 0.00% | 0.0% |
Q2 2022 | $2,230,000 | -11.1% | 99,908 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $2,509,000 | -0.8% | 99,908 | +41.5% | 0.00% | 0.0% |
Q4 2021 | $2,529,000 | +65.0% | 70,587 | +96.0% | 0.00% | 0.0% |
Q3 2021 | $1,533,000 | +7.7% | 36,012 | +9.6% | 0.00% | 0.0% |
Q2 2021 | $1,423,000 | +5.3% | 32,861 | -0.9% | 0.00% | 0.0% |
Q1 2021 | $1,352,000 | +14.7% | 33,151 | +27.3% | 0.00% | 0.0% |
Q4 2020 | $1,179,000 | +15.2% | 26,040 | -10.0% | 0.00% | 0.0% |
Q3 2020 | $1,023,000 | -25.0% | 28,918 | -20.0% | 0.00% | 0.0% |
Q2 2020 | $1,364,000 | +15.7% | 36,152 | -11.4% | 0.00% | 0.0% |
Q1 2020 | $1,179,000 | -49.4% | 40,796 | -9.2% | 0.00% | -50.0% |
Q4 2019 | $2,329,000 | -47.2% | 44,909 | -44.1% | 0.00% | -60.0% |
Q3 2019 | $4,413,000 | +35.2% | 80,400 | +0.0% | 0.01% | +25.0% |
Q2 2019 | $3,265,000 | -28.8% | 80,390 | -44.0% | 0.00% | +33.3% |
Q1 2019 | $4,588,000 | +83.9% | 143,427 | +93.2% | 0.00% | 0.0% |
Q4 2018 | $2,495,000 | -16.3% | 74,224 | +5.0% | 0.00% | -25.0% |
Q3 2018 | $2,981,000 | +2.5% | 70,678 | -22.2% | 0.00% | 0.0% |
Q2 2018 | $2,908,000 | -43.2% | 90,881 | -11.8% | 0.00% | -42.9% |
Q1 2018 | $5,121,000 | -14.9% | 102,987 | -7.8% | 0.01% | -12.5% |
Q4 2017 | $6,021,000 | -1.8% | 111,694 | +5.7% | 0.01% | -11.1% |
Q3 2017 | $6,132,000 | +53.6% | 105,716 | +30.7% | 0.01% | +50.0% |
Q2 2017 | $3,992,000 | +31.0% | 80,904 | +15.3% | 0.01% | +20.0% |
Q1 2017 | $3,047,000 | +5.1% | 70,153 | +18.4% | 0.01% | 0.0% |
Q4 2016 | $2,900,000 | -35.3% | 59,234 | -36.8% | 0.01% | -37.5% |
Q3 2016 | $4,484,000 | +47.2% | 93,715 | +62.4% | 0.01% | +33.3% |
Q2 2016 | $3,047,000 | +9.1% | 57,719 | 0.0% | 0.01% | +20.0% |
Q1 2016 | $2,792,000 | +418.0% | 57,719 | +308.7% | 0.01% | +400.0% |
Q4 2015 | $539,000 | – | 14,124 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |